^
    CANCER:
    Ovarian Serous Adenocarcinoma
    Related cancers:
    BRAF V600E
    Ovarian Serous Adenocarcinoma
    binimetinib + encorafenib
    Sensitive
    :
    C1
    BRCA2 mutation
    Ovarian Serous Adenocarcinoma
    olaparib
    Sensitive
    :
    C1
    BRCA1 mutation
    Ovarian Serous Adenocarcinoma
    olaparib
    Sensitive
    :
    C1
    KRAS G12D
    Ovarian Serous Adenocarcinoma
    VS-6766 + VS-6063
    Sensitive
    :
    C3
    KRAS G12A
    Ovarian Serous Adenocarcinoma
    VS-6766 + VS-6063
    Sensitive
    :
    C3
    KRAS G12V
    Ovarian Serous Adenocarcinoma
    VS-6766 + VS-6063
    Sensitive
    :
    C3
    Choline elevation
    Ovarian Serous Adenocarcinoma
    pembrolizumab
    Sensitive
    :
    C3
    BRCA1 mutation
    Ovarian Serous Adenocarcinoma
    AZD1775
    Sensitive
    :
    C4
    GOPC-ROS1 fusion
    Ovarian Serous Adenocarcinoma
    crizotinib
    Sensitive
    :
    C4
    ER Y537N
    Ovarian Serous Adenocarcinoma
    fulvestrant
    Sensitive
    :
    C4
    BRCA2 mutation
    Ovarian Serous Adenocarcinoma
    LY2606368 + LY3023414
    Sensitive
    :
    D
    BRAF L485-P490 deletion
    Ovarian Serous Adenocarcinoma
    LY3009120
    Sensitive
    :
    D
    PRMT1 underexpression
    Ovarian Serous Adenocarcinoma
    carboplatin
    Sensitive
    :
    D
    PRMT1 underexpression
    Ovarian Serous Adenocarcinoma
    cisplatin
    Sensitive
    :
    D
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES